Mueller Water Products Reports 2020 Second Quarter Results
Increased Net Sales 10.1 percent to $257.7 millionReported Net Income per Diluted Share of $0.15Delivered Adjusted Net Income per Diluted […]
Duluth Holdings Provides Business Update and Announces Partnership with American Red Cross
Re-opening 20 Retail Stores Credit Line Increased to $150 MillionMOUNT HOREB, Wis., May 04, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. […]
Dealnet Receives Meeting Requisition Materials from Small Dissident Group
TORONTO, May 04, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announces that it […]
Huttig Building Products, Inc. Announces First Quarter 2020 Results and Provides Business Update on COVID-19 Response
First Quarter 2020 Highlights (as compared to prior year quarter):Net sales increased 2.8% to $203.0 millionGross margin increased 120 basis […]
Avis Budget Group Reports First Quarter 2020 Results and Pandemic Response Actions
PARSIPPANY, N.J., May 04, 2020 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) today reported results for its first […]
TSX News -
Alcanna Postpones Filing of First Quarter 2020 Financial Statements, MD&A and Related Filings
EDMONTON, Alberta, May 04, 2020 (GLOBE NEWSWIRE) — Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today announced that the […]
CB Financial Services, Inc. Announces First Quarter 2020 Financial Results
WASHINGTON, Pa., May 04, 2020 (GLOBE NEWSWIRE) — CB Financial Services, Inc. (“CB” or the “Company”) (NASDAQGM: CBFV), the holding […]
CorePoint Lodging Moves 2020 Annual Meeting of Stockholders to Virtual-Only Format
IRVING, Texas, May 04, 2020 (GLOBE NEWSWIRE) — CorePoint Lodging Inc. (NYSE: CPLG) (“CorePoint” or the “Company”) today announced that […]
CapStar Announces CFO Transition
NASHVILLE, Tenn., May 04, 2020 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ: CSTR) announced today the hiring of Michael […]
Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
— Robust efficacy and evidence of a dose response from single intravitreal injection (IVT) of ADVM-022 —— Long-term durability beyond […]
